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“It is not the critic who counts; not the man who 
points out how the strong man stumbles, or where the 
doer of deeds could have done them better. The credit 
belongs to the man who is actually in the arena, 
whose face is marred by dust and sweat and blood; who 
strives valiantly; who errs, who comes short again 
and again, because there is no effort without error 
and shortcoming; but who does actually strive to do 
the deeds; who knows great enthusiasms, the great 
devotions; who spends himself in a worthy cause; who 
at the best knows in the end the triumph of high 
achievement, and who at the worst, if he fails, at 
least fails while daring greatly, so that his place 
shall never be with those cold and timid souls who 
neither know victory nor defeat.” 
― Theodore Roosevelt 
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ABSTRACT 
 
My doctoral thesis examines the prerequisites of replication for three posi-
tive-strand RNA viruses, Chikungunya virus (CHIKV - alphavirus), Semliki For-
est virus (SFV - alphavirus) and Flock House virus (FHV - nodavirus).
 CHIKV is a mosquito-borne RNA virus that causes high fever, conspic-
uous rashes and unbearable joint pain. Semliki Forest virus (SFV) has been ex-
tensively studied as a model to comprehend the replication strategies of alpha-
viruses because of its low pathogenicity. A characteristic feature of alphavirus 
replication is the formation of membranous invaginations termed spherules, as-
sociated with the plasma membrane. Spherules act as genome factories as they 
are the sites of active viral replication and release nascent viral RNA strands into 
the cytoplasm through a bottleneck-like structure. We created a trans-replication 
system specific for CHIKV that would be flexible and presents no danger to the 
scientist. In this system, the viral replicase proteins are expressed from a DNA 
plasmid while the RNA template is produced from a second plasmid, in mam-
malian cells. This allowed for the study of viral replication without generating 
infectious particles. It also enabled the visualisation of spherules and labelling of 
all viral replicase proteins with fluorescent or small immunological tags while pre-
serving their function. Various mutations associated with noncytotoxic pheno-
types were analysed and the results showed no correlation between the level of 
RNA replication and cytotoxicity. Moreover, the trans-replication system was 
used to elucidate that the cysteine residue of CHIKV nsP2 at position 478 is 
responsible for its protease activity and essential for replicase polyprotein pro-
cessing. Trp479 of nsP2 also plays a vital role in RNA replication. 
 The insect nodavirus, FHV, verges upon the properties of a ‘universal 
virus’ as it can replicate in a wide range of hosts. Only the replicase protein A is 
required for its replication.  An efficient FHV trans-replication system was estab-
lished in mammalian cells. The outer surface of mitochondria displayed pouch-
like invaginations with a ‘neck’ structure opening towards the cytoplasm. High-
level synthesis of both genomic and subgenomic RNA was detected in vitro using 
mitochondrial pellets isolated from transfected cells. The newly synthesized RNA 
was found to be of positive polarity. This system was used to investigate the cap-
ping enzyme domain of protein A, both in cells and in vitro. Mutating the most 
conserved amino acids of the capping domain abolished or reduced viral RNA 
synthesis. Surprisingly, transfection of capped RNA template did not rescue the 
replication activity of the mutants. FHV and alphaviruses show evolutionarily 
intriguing similarities in their replication complexes and RNA capping enzymes. 
 The biological systems presented in this study offer valuable knowledge 
that could be exploited to understand the replication of other RNA viruses and 
also open up new avenues for the elucidation of key virus-host interactions. 
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INTRODUCTION 
 
1.1   Viruses 
 Viruses are minuscule hijackers of life. They are obligatory infectious 
agents that rely solely on the species they infect for their replication. The origin 
of viruses is contentious. To date, there are three main concepts as to where they 
might come from; the virus-first, the progressive and the regressive hypotheses31, 
103, 150. The virus-first hypothesis assumes that the existence of viruses predates 
that of cellular organisms. From a ‘primitive soup’ of interacting and competing 
nucleic acids and proteins, viruses would have emerged as individual organisms31. 
Even if this speculation might explain why the genome replication strategies of 
the viral world is more diverse than that of the cellular world, it has been widely 
rejected for two reasons: 1) in an early RNA world of free molecules, protein 
synthesis would have been a major challenge and, 2) our understanding of con-
temporary viruses suggests that an intracellular stage would have been neces-
sary31. The progressive hypothesis, also known as the escape hypothesis, suggests 
that genetic elements gained mobility and eventually were able to exit cells and 
enter others. This parasitic-driven premise proposed that bacteriophages were 
derived from bacterial genomes while eukaryotic viruses came from eukaryotes. 
However, the lack of homology with archaeal viruses remains unexplained.103 The 
regressive (or reduction) hypothesis suggests that the ancestors of viruses were 
complex, self-sufficient and lived in symbiosis with other organisms. Over time, 
the symbiotic relationship turned parasitic due to the loss of essential genetic 
information until they were unable to replicate independently. This theory is 
questionable as no intermediate has been identified, although some argue that the 
Mimivirus is the missing link between a cell and a virus106. Each one of these 
hypotheses have serious drawbacks. Nonetheless, by one way or another, it is 
undeniable that viruses have played a critical role in evolutionary shifts. 
1.2   Positive-strand RNA viruses 
 The genetic material of RNA viruses can be single-stranded or double-
stranded; positive sense or negative sense. Positive sense (or plus-strand) RNA 
viruses possess genetic material that is ready for translation by the host cell upon 
virus entry. Although the diversity of these viruses is immense, they do share 
commonalities; plus-strand RNA viruses code for an RNA-dependent RNA pol-
ymerase (RdRp) and their replication occurs in ‘organelles’ or compartments built 
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from their host’s membranous structures. The type of membrane favoured is dif-
ferent for each virus family. For example, picornaviruses prefer to replicate in 
double-membraned vesicles originating from the Golgi membranes whereas al-
phaviruses prefer the plasma membrane48. There are about 214 RNA viruses 
known to infect humans and more are discovered every year151. Most RNA vi-
ruses infecting humans have zoonotic origins meaning that they can infect other 
vertebrate hosts or were able to do so previously. While it is possible for some 
viruses to cross species barriers and become human-adapted viruses, this happens 
very rarely80. In this study, we focused on the families Togaviridae, specifically the 
genus alphavirus (Chikungunya virus – CHIKV and Semliki forest virus – SFV) 
and an alphanodavirus (Flock house virus – FHV). Out of these three, only 
CHIKV can cause serious illness in humans.  
1.3   Alphaviruses 
 Alphaviruses are arthropod-borne and are usually transmitted to humans 
via mosquito vectors11, 126, 134. Alphaviruses have been found in all continents ex-
cept Antarctica. There are about 30 species recorded so far and they are often 
referred to as Old World or New World viruses according to their geographical 
distribution and historical occurrence108. Some of them are listed in Table 1 and 
include the locations where strains have been isolated as well as their medical 
relevance. Most of the Old World alphaviruses of medical importance cause ar-
thritis-like syndromes whereas the New World alphaviruses cause encephalitis. 
The Old World viruses have been typically discovered in Eurasian-African-Aus-
tralasian regions whereas the New World alphaviruses were found in the Ameri-
cas. This worldwide distribution of alphaviruses has been attributed to various 
factors. For example, Sindbis virus (SINV) isolates have a very wide global dis-
tribution and are believed to have been propagated by avian hosts. In fact, several 
strains of alphaviruses have been isolated in migratory birds and it appears that, 
once introduced in a new area, these viruses have been able to establish a niche, 
evolve and persist in the formerly unaffected region134. However, in the case of 
CHIKV, human travel has been the cause of dissemination of the virus to the 
Caribbean islands, southern Europe and the Americas at a very rapid rate in 
201330, 138, 146. Newly-introduced alphavirus cases sometimes result in explosive 
epidemics but also fail to establish a persistent endemic cycle in the region (ex-
ample: Ross River virus from Australia to the South Pacific) thus, resulting in the 
virus to die out after infecting most of the population134. 
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Table 1: Classification of alphaviruses13-14, 65, 88, 90, 108, 122, 134, 145, 147. 
Old World 
alphaviruses 
Geographical 
distribution 
Symptoms 
in humans 
Barmah Forest virus 
(BFV) 
Australia Mild fever, rash, 
polyarthritis 
CHIKV 
North, South America, 
Africa, India, Indian 
Ocean islands, Europe 
Fever, arthralgia, rash 
Eilat virus (EILV) Africa, Middle East None 
O’nyong’nyong (ONNV) Africa Fever, arthralgia, rash 
Ross River virus (RRV) Australia, Oceania Fever, arthralgia, rash 
Sagiyama virus (SAG) Japan None 
SINV Africa, Asia, Europe, 
Australia, Scandinavia 
Mild fever, rash, 
muscle pain 
SFV Africa, Eurasia 
Fever, myalgia, 
arthralgia 
New World 
alphaviruses 
Geographical 
distribution 
Symptoms 
in humans 
Eastern equine 
encephalitis virus (EEEV) 
North, South America 
Febrile illness, 
encephalitis 
Everglades virus (EVE) Florida 
Fever, myalgia, 
pharyngitis 
Highlands J virus (HJ) Eastern USA None 
Mayaro (MAY) South America 
Acute febrile illness, 
arthralgia, myalgia, rash 
Venezuelan equine 
encephalitis virus (VEEV) 
Central, North, South 
America, Mexico 
Febrile illness, 
encephalitis 
Western equine 
encephalitis virus (WEEV) North, South America 
Febrile illness, 
encephalitis 
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1.3.1   Semliki Forest virus (SFV) 
 In 1942, SFV was isolated from Aedes (Ae.) mosquitoes caught in an un-
inhabited area of the Semliki Forest in Uganda (Bwamba County)127. The virus 
was found to be pathogenic to mice, rabbits and guinea pigs after subcutaneous 
injections or lethal following intracerebral inoculations. Several passages in mice 
and rabbits enhanced the virulence of SFV ultimately causing death. Rhesus mon-
keys developed mild fever for 2 days following subcutaneous inoculation with 
the virus but the symptoms did not persist. However, intracerebral inoculation 
of healthy rhesus monkeys was lethal126. The strains of SFV are usually avirulent 
for humans. So far, there has been only one reported fatal case of SFV encepha-
litis in a laboratory worker. Some variants of SFV in central Africa can cause 
severe headache, fever, myalgia and arthralgia134.  
1.3.2   Chikungunya virus (CHIKV) 
 In 1952, an outbreak affecting the Makonde people of Tanzania was re-
ported. The symptoms were similar to Dengue fever. However, the pathogen 
isolated in that case was a novel arbovirus81, 87. It is very plausible that previous 
outbreaks associated with Dengue virus were in fact caused by CHIKV as early 
as the year 1779125. CHIKV causes high fever, acute myalgias, rash and chronic 
severe arthritis81, 134. The name Chikungunya was given due to the contorted pos-
ture the patients would adopt due to painful arthralgia. It is derived from the 
Makonde root verb kungunyala and means ‘to walk bent over’86. 
Genotypes of CHIKV are classified based on the E1 gene namely, the 
Asian (A), East/Central/South African (ECSA) and West Africa (WA) geno-
types87, 125. The current consensus is that all the CHIKV strains originated 500 
years ago from a common ancestor in East Africa and the virus was introduced 
in Asia in the 1950s148. While these genotypes used to be confined to their loca-
tion, cases of ECSA have been reported in Asia as well125. The CHIKV trans-
replication system described in publication I was designed based on an ECSA 
strain isolated from Reunion island in 2006 (LR2006-OPY). ECSA is not always 
confined to its geolocation as it has been detected in West Africa. This means 
that the genotypes can sometimes overlap spatially148. 
In 2004, a CHIKV epidemic started in East Africa. By 2005, the disease 
had spread from Kenya to Mauritius, La Réunion and other islands in the Indian 
Ocean148. The strain isolated from La Réunion was of ECSA lineage and was 
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found to have an A226V mutation in the E1 glycoprotein that conferred a con-
siderable increase in infectivity and viral dissemination in Ae. albopictus but not 
Ae. aegypti, the usual host139. Ae. albopictus can survive winters in temperate cli-
mates in contrast to Ae. aegypti. Hence, this acquired advantage favours persis-
tence of the virus in these regions where Ae. aegypti was scarce. In late 2005, epi-
demics ensued in India and from there, spread to southern Europe, southeast 
Asia and the Americas148. Then in 2009, another isolate was detected harbouring 
a L210Q mutation in the E2 glycoprotein. This mutation increased virus infec-
tivity for Ae. albopictus although not as much as the A226V mutation94. All these 
events are depicted in Figure 1148. There were no current CHIKV outbreaks at 
the time this thesis was written 
1.3.3   Structure of the virion and life cycle 
 Alphaviruses consist of an icosahedral nucleocapsid (T = 4) surrounded 
by a close-fitting envelope. The fenestrated nucleocapsid is composed of 240 
copies of a capsid protein of about 30 kDa55, 134. It has been suggested that the 
numerous Arginine, Lysine and Proline residues at the N-terminus of the capsid 
protein protrude inward and interact electrostatically with the viral RNA within 
Figure 1: Worldwide distribution of CHIKV strains and movement of outbreaks 
(Reproduced from Ref 148, Copyright © 2019 Taylor & Francis; permission to 
reprint http://www.tandfonline.com). 
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the nucleocapsid. Enclosed in the nucleocapsid is a single-stranded RNA of pos-
itive polarity134. The envelope consists of a lipid bilayer of about 4.8 nm in thick-
ness, derived from the host, in which 240 copies of E1 and E2 viral proteins are 
embedded. The envelope is rich in cholesterol and sphingolipids55, 134. E1 and E2 
proteins are glycosylated, about 50 kDa each, and have membrane-spanning an-
chors in their C-terminal regions134. Together, E1 and E2 form homodimers and 
heterodimers, ultimately interlaced to form trimeric spikes on the surface of the 
virion134. E1 mostly stay at the base of the spikes and form a lattice on the surface 
of the virion.  The N-terminus of E2 contains a receptor attachment site pro-
truding externally in a leaf-like structure at the top of the spike whereas the C-
terminus of E2 interacts with the nucleocapsid55.  
 Upon infection of a mammalian cell, the virus attaches to the host’s mem-
brane receptor MXRA8 mostly via the protein E2155. The virion is then endocy-
tosed in a clathrin-dependent manner55. In the endosome, ensuing events include 
a series of conformational changes as E1-E2 heterodimers disassemble to form 
E1 homotrimers and E2 monomers55, 134.  This destabilisation occurs due to acid-
ification as the endosome matures, consequently revealing the distal loop of E1. 
The viral bilayer fuses with the endosomal membrane and the nucleocapsid is 
released in the cytoplasm. The presence of cholesterol in the membrane is vital 
for this process to occur55. 
 Next, the nucleocapsid disassembles in the cytoplasm, rendering the viral 
RNA available for replication to begin. Several hypotheses exist as to how this 
process occurs. It has been suggested that ribosomes facilitate the nucleocapsid 
uncoating process149. Alternatively, based on experiments involving Ae. albopictus 
cells, Lanzrein et al proposed that endosome acidification causes an amphiphilic 
portion of E1 to fold back into the membrane, creating a pore by interacting with 
other E1 subunits. The pores allow protons to freely enter the nucleocapsid and 
initiate uncoating66. Furthermore, endosomes undergoing acidification also un-
dergo active Cl- accumulation129. Considering that the nucleocapsid is destabilised 
by high salt concentration19, it is likely that the release of viral RNA is a process 
that is initiated by endosomal maturation. 
 In the cytoplasm, the newly released viral RNA is translated by the host’s 
cellular machinery and replicated. Alphavirus replication is explained in more de-
tail in section 1.3.4. Briefly, the first two-thirds of the viral genome is translated 
into a polyprotein that is cleaved into non-structural proteins (nsPs) also referred 
to as replicase proteins. The nsPs form a complex that recruit and make several 
copies of the viral genomic RNA134. The complex also generates a smaller 26S 
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RNA from a subgenomic promoter within the viral genome that is translated into 
a structural polyprotein and cleaved into the capsid, E3,  pE2 (precursor for E2 
protein), 6K and E155. 
Conserved sequences in the viral genome act as packaging signals55. A 
smaller protein, 6K, is also incorporated in the virion in smaller amounts than 
the other structural proteins (about one 6K molecule for every ten E1-E2 heter-
odimer)55, 72. 6K plays an important role in proper folding of E1-E2 heterodimers, 
affecting spike formation and egress78. Moreover, 6K was suggested to affect the 
selection of lipids to be used in virus assembly and facilitates the mechanisms 
involving membrane curvature in the budding process72. The absence of 6K ap-
pears to affect egress to a greater extent in mosquito cells compared to mamma-
lian cells72. Assembly of viral particles is mediated by electrostatic interactions 
which also ensure the stability of the virion134. 
1.3.4   Viral genome and replication 
 The nsP amino acid (aa) sequences of CHIKV and SFV are 71% identical 
and therefore, the current understanding of CHIKV replication is partly derived 
from that of SFV replication97. The genome is a single-strand of RNA about 12 
kb in length. The 5' end is capped and the 3' end is polyadenylated60. There are 
two open reading frames (ORFs) in the genome from which a non-structural 
polyprotein precursor and a structural polyprotein precursor are translated. 
CHIKV genome replication is portrayed in Figure 2. This process is active only 
during the first 6 – 8 hours of infection before the cellular translational machinery 
is shut down119. The non-structural polyprotein precursor can be expressed as 
P123 and P1234 due to the presence of an opal termination codon at the C-
terminus of nsP3 and translational readthrough134. In some CHIKV isolates, such 
as the LR2006-OPY (ECSA) strain, the opal codon was found to be replaced by 
an arginine codon and therefore, this strain only expresses P1234 as the non-
structural polyprotein precursor119. Next, P1234 is cleaved into individual nsPs 
and the RNA genome is recruited to the plasma membrane by nsP1. It is likely 
that the initiation of polyprotein processing (cleavage) precedes RNA recruitment 
although the exact order of events is unknown. The protease domain of nsP2 is 
responsible for polyprotein processing and the order of cleavages is based on the 
conformational changes the polyprotein undergoes during processing, the spatial 
rearrangement and the availability of the cleavage sites74-75. From P1234, nsP4 is 
cleaved first. Together, P123, nsP4 and the viral RNA form an early replicase 
complex. The early replicase complex launches the synthesis of an RNA strand 
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of negative polarity (minus-strand), complementary to the viral genome and 
hence, forms a dsRNA intermediate67. Concurrently, the plasma membrane 
bends, morphs and swells into a balloon-like structure termed spherule with an 
aperture facing the cytoplasm. In the spherule, further polyprotein processing 
occurs as nsP1 is cleaved next (in cis cleavage)143. The nsP1+P23+nsP4 complex 
is short-lived and rarely detected because of the very rapid subsequent step: cleav-
age of P23 into nsP2 and nsP3 (in trans cleavage)143. By the time the polyprotein 
has been cleaved to all the individual nsPs, minus-strand production is most likely 
completed. nsPs1-4 form a late replicase complex and use the minus-strand for 
Figure 2: Polyprotein processing and viral RNA synthesis during CHIKV repli-
cation. P1234 is cleaved into the distinct nsPs while the RNA is recruited to gen-
erate a minus-strand, which is in turn used for the production of plus-strands. 
The replication complex is membrane-bound but its stoichiometry and its locali-
sation within the spherule are unknown. The scissor icons represent the cleavage 
sites, SGP means subgenomic promoter, solid lines are plus-strands and dotted 
lines are minus-strands. 
12 
 
the generation of plus-strands (nascent genomic RNA) to be packaged in virions 
or to be recruited for the formation of new spherules. The late replicase complex 
also produces a smaller RNA, the subgenomic RNA (SgRNA). SgRNA exits the 
spherules to be translated by the cellular translational machinery as a structural 
polyprotein precursor to be further cleaved to C, E3, E2, 6K and E1 involved in 
the packaging and assembly of virions. Interestingly, it was found for SINV and 
SFV that, in the absence of the capsid protein, the viral genome can exit cells in 
the form of infectious microvesicles coated with spike proteins111-112. 
Cleavage events and formation of the replication complex are very dy-
namic events. It is likely that the replication complex undergoes several confor-
mational changes when it switches from the plus-strand to using the minus-strand 
as the template. nsP2 is thought to assist in this process as the final cleavage 
events might inactivate minus-strand synthesis and plus-strand synthesis is initi-
ated as the replication complex reassembles117. Whether the nsPs exist in an 
equimolar fashion is still unknown and so is the influence of host factors present 
in the spherule.  
1.3.5   Replicase protein nsP1 
 As previously mentioned, the prerequisites for replication of the viral ge-
nome are the viral genomic RNA and the replicase proteins (Figure 3). However, 
nsPs also have other roles and have been found in cellular locations other than 
spherules. An amphipathic helix in the middle of nsP1 and palmitoylation are 
responsible for the anchoring of the replication complex to the plasma mem-
brane114, 133. A study involving SFV polyproteins proved that nsP1 alone is re-
sponsible for the membrane targeting of the replication complex. In this study 
by Salonen et al, a cysteine residue at position 478 in the protease catalytic site of 
SFV nsP2 (further denoted as CA) was mutated to alanine to create uncleavable 
versions of SFV polyproteins. P12CA3 and P12CA were associated with the plasma 
membrane while P2CA3 and P34 were associated with cytoplasmic areas of the 
cell116. 
In addition to its ability to act as a membrane anchor, nsP1 exhibits en-
zymatic features of methyltransferases (MT) and guanylyltransferases (GT). A 
histidine residue at position 38 in SFV nsP1 is vital for GT activity4. nsP1 is re-
sponsible for the 5' capping of the viral RNA genome, an important feature for 
alphavirus gene expression and conferring protection from targeted degradation. 
A capping reaction involves the methylation of GTP by nsP1, forming a covalent 
7meGMP+nsP1 complex, followed by the transfer of the 7meGMP to the newly-
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synthesised RNA genomic and SgRNA via the GT activity of nsP1. This results 
in a 7meGpppA cap structure added to the 5' of the viral RNAs2. In the case of 
SINV, it was found that not all RNA strands are capped and the ratio of capped 
to non-capped viral RNAs depends on the host (mammalian cells vs mosquito 
cells). Moreover, the presence of non-capped viral genomic and SgRNA activated 
the host’s innate immune system via the production of type I interferon128. SINV 
nsP1 remains functional in the absence of lipids, showing that membrane associ-
ation is not vital for its enzymatic functions in contrast to SFV nsP1, thus show-
ing a variation in the requirements for enzymatic activity among alphaviruses114. 
1.3.6   Replicase protein nsP2 
nsP2 acts as a protease and helicase. The nucleoside triphosphatase 
(NTPase) and RNA-dependent 5'-triphosphatase enzymatic regions are posi-
tioned at the N-terminus whereas the proteolytic region is at the C-terminus of 
nsP2140. nsP2 is involved in polyprotein processing indicating that it is responsible 
for the cleavage of the polyprotein precursor into individual nsPs. This protease 
domain is essential for viral replication. In SINV, cleavage occurs in trans alt-
hough the 1/2 and 3/4 sites can also be cleaved in cis. Moreover, the processing 
state of the polyprotein in which nsP2 is found determines the efficiency of pro-
tease activity at the nsP junctions23, 114, 143. For SFV, nsP2 has a high affinity for 
the 3/4 site75, 144. 
Due to aa sequence similarity between conserved sequences of E. coli 
helicases and the N-terminus of nsP2, it has been suggested that nsP2 is involved 
in duplex unwinding during RNA replication43. It was found that the aa residues 
166– 630 of CHIKV nsP2 lack RNA helicase activity58. The lysine residue in the 
helicase region of nsP2 at position 192 is very conserved. The K192N mutation 
results in reduced infectivity but the progeny virions are capable of reversion109. 
The helicase properties of SFV nsP2 has been found to be dependent on Mg2+ 
and ATP concentrations42. During viral replication, nsP4 synthesises new RNA 
strands in a 5' to 3' fashion while nsP2 unwinds RNA in the same direction. 
Therefore, coordination and regulation of these two processes is critical21. 
When it is not part of the replication complex, CHIKV nsP2 localises in 
the nucleus where it can block the Jak-Stat signalling pathway and prevents tran-
scription of interferon-stimulated genes35. Transcriptional shutoff is lethal for the 
cell. Furthermore, nsP2 mediates the degradation of Rpb1, the catalytic subunit 
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of RNA polymerase II, by inducing ubiquitination and consequently causes dis-
assembly of the RNA polymerase II complex. This leads to the termination of 
transcription and degradation via cellular pathways. The C-terminus and NTPase 
activity of nsP2 seem to be the culprits probably through the strong binding of 
nsP2 to DNA and locking it in a conformation whereby RNA polymerase II is 
unable to proceed5. The cytopathic effects seen in cells during alphavirus infec-
tions varies. For example, CHIKV nsP2 is not as efficient at shutting down the 
host’s translation machinery compared to SINV nsP26. The proline residue at 
Figure 3: Schematic view of CHIKV nsPs. Amino acid residues of significance 
for the life cycle of the virus are shown (numbers). 
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position 718 in CHIKV nsP2 is responsible for the cytotoxicity of nsP2 and sub-
stitution to glycine renders the protein less cytotoxic135. In SINV, the correspond-
ing proline 726 mutation in the MT-like domain reduces cytotoxic effects and 
decrease viral replication39. Moreover, the nsP2 of New World viruses, such as 
VEEV, is rather harmless to the cell and is seen exclusively in the cytoplasm62. 
The VEEV capsid shuttles between the cytoplasm and the nucleus, inducing cy-
totoxicity by blocking nuclear transport via the CRM1 and importin α/β1 nuclear 
transport proteins38, 76. When the nuclear localisation signal (NLS) at position 649 
of CHIKV nsP2 is altered, nuclear transport does not occur. While this is true 
for the WA CHIKV strain, the same mutation in the ECSA genotype does not 
have the same consequence140. Newly-synthesised RNA strands (both genomic 
and subgenomic) are processed to a 5′ diphosphate moiety by the NTPase of 
nsP2 prior to capping142. 
1.3.7   Replicase protein nsP3 
 nsP3 is composed of a macrodomain, a zinc-binding domain and a hy-
pervariable domain140. Macrodomains are very conserved across alphaviruses and 
some other unrelated viruses such as coronaviruses. Macrodomains bind to 
mono-ADP-ribose or poly-ADP-ribose and selectively remove ADP-ribose from 
aspartate and glutamate but not lysine residues77, 79. This feature appears to play 
an important role in the virus’ attempt to fight against antiviral responses. Poly-
ADP-ribose synthesis is enhanced by the nuclear polymerase PARP-1 due to in-
flammation and stress induced during alphavirus infection. The result is a decline 
in the level of ATP and NAD in the cell, and the release of an apoptosis-inducing 
factor89. Moreover, tampering with the CHIKV macrodomain either attenuates 
the virus or impairs replication completely79. Analysis of the crystal structure of 
CHIKV macrodomain revealed that the D10 residue is involved in the recogni-
tion of adenines thus rendering the macrodomain capable of binding to RNA77. 
Analysis of the Zinc-binding domain (also known as alphavirus unique 
domain – AUD) of SINV nsP3 showed that it contains a unique zinc-binding 
fold consisting of four cysteine residues coordinating one zinc molecule alto-
gether having putative RNA binding capabilities121. In CHIKV, mutating the cys-
teine residues 262 and 264 to alanine renders the virus unable to replicate in ro-
dent, mosquito and human cell lines. Moreover, mutations V260A/P261A close 
to the zinc-binding cysteines also abolish CHIKV viral replication either by pre-
venting binding to important host factors or because of the change in the struc-
tural conformation of the protein37. 
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The hypervariable domain possesses a hyperphosphorylated region and a 
proline rich region at the C-terminus which is believed to interact with several 
cellular host factors44. The proline rich region is the site for the binding of Src-
homology (SH3) of amphiphysin-1 and amphiphysin-2 to nsP393. Amphiphysin 
proteins have the ability to cause membrane curvature and thus could be re-
cruited by the replication complex to assist in spherule formation45, 47. When it is 
not in the replication complex, nsP3 localises in large cytoplasmic aggregates. 
This feature of nsP3 is independent of viral replication as the protein alone has 
been detected in these foci44. During active CHIKV replication, nsP3 binds to 
the host protein Ras-GTPase-activating protein G3BP via two FGDF motifs in 
its sequence99. G3BP is an RNA-binding protein expressed in three isoforms that 
has an important role as a stress granule nucleating protein and aggregates are 
formed due to stress events occurring in cells8, 137. nsP3 recruits G3BP to its cy-
toplasmic aggregates, thus inhibiting stress granules formation98. 
Tampering with the N-terminal macrodomain does not affect this locali-
sation but mutations in the hypervariable area of the C-terminal region gave rise 
to filamentous structures instead of foci. Moreover, deletions or point mutations 
in the SH3 domains, annihilates CHIKV replication. Association of nsP3 with 
G3BP is mediated via the SH3 domain34. Moreover, degradation of SFV nsP3 
during infection is believed to play a role in regulating the levels of nsP444. 
1.3.8   Replicase protein nsP4 
nsP4 is the RNA-dependent RNA polymerase (RdRp) and contains a 
GDD motif necessary for its activity. nsP4 is usually expressed in smaller 
amounts compared to the other nsPs. The first reason for that is the presence of 
the opal codon readthrough as mentioned earlier. Secondly, in the case of SINV 
nsP4, the presence of a tyrosine residue at the N-terminus renders it highly un-
stable and subject to degradation by the ubiquitin-dependent N-end rule path-
way24. Little is known about the N-terminus of CHIKV nsP4. However, previous 
studies with SINV nsP4 revealed that the N-terminus is highly flexible and me-
diates functional interactions between the nsPs113. A recombinant SINV nsP4 
expressed as a N-terminal SUMO fusion protein revealed nsP4’s ability to act as 
a terminal adenosyl transferase (TATase) and initiate de novo minus-strand synthe-
sis in vitro in the presence of P123. Deletion of 97 aa at the N-terminus of nsP4 
abolished RNA synthesis although the protein was still capable of terminal addi-
tion of nucleotides110. nsP4 being the most conserved protein between alpha-
viruses, it is very likely that CHIKV undergoes the same processes. Tight control 
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of nsP4 appears to be vital for alphavirus replication as the virus goes out of its 
way to limit its intracellular concentration to meet minimum requirements. Heat 
shock protein 90 (HSP-90) has been proposed to be of assistance in the stabili-
sation of nsP4 and chaperones the formation of the replication complex by di-
rectly interacting with nsP3 and nsP4107. Ribavirin is an RNA nucleoside analog 
that has a mutational effect on CHIKV nsP4 following multiple passages in mos-
quito and mammalian cells. The cysteine residue at position 483 was mutated to 
tyrosine. The result was an increase in replication fidelity and resistance to ribavi-
rin and 5-fluorouracil as well18. Recently, a CHIKV in vitro replication assay was 
established by Albescu et al and revealed the synthesis of an RNA transcript, 
termed RNA II. The length corresponded to span from the 5' to the start of the 
subgenomic promoter. RNA II was also found in infected cells7. 
1.3.9   Spherule formation and cytopathic vesicles during alphavirus repli-
cation 
 Assembly of the early replication complex occurs in concert with spher-
ule formation. CHIKV spherules emerge from the plasma membrane and have a 
neck-like opening to the cytoplasm. This opening is about 5-10 nm in diameter 
and guarantees that only the necessary components of replication such as nucle-
otides and other host factors, enter the spherule but also allows the exit of newly 
synthesised plus-strands of RNA36. As viral replication is initiated, a complemen-
tary minus-strand is generated from the first positive-sense RNA strand con-
tained in the virus that entered the cell. Minus-strands are required for spherule 
formation but have not been detected in the cytoplasm33, 49, 57, 131. This suggests 
that the minus-strand most likely remains in the spherule, always acting as a tem-
plate for RNA synthesis. Genomic and subgenomic RNAs are produced at the 
same time. Hence, it is possible that the replication complex is capable of synthe-
sising multiple copies simultaneously. There is no evidence that the original plus-
strand recruited exits the spherule after production of the minus-strand but it is 
logical to assume so; first because this strand would undoubtedly undergo the 
same ‘spherule-exiting mechanism’ as the newly synthesised plus-strands and sec-
ondly to free up space in an already crowded subcellular environment. Hence, 
this assumption implies that the replication of alphaviruses is semi-conservative. 
In a wildtype viral setting, spherules are usually about 60 nm in diameter. How-
ever, it has been shown with SFV that the size of the spherules depends on the 
length of the RNA56. 
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 Cytopathic vesicles (CPVs) are large cytopathic vacuoles resulting from 
the internalisation of a large number of spherules. This cellular event leads to the 
formation of a modified endosomal/lysosomal structure lined with spherules 
with the neck facing the exterior of the CPV124, 132. Internalisation of spherules 
happens frequently for SFV but to a lesser extent during SINV infection. CHIKV 
replication complexes stay mostly at the plasma membrane although internalisa-
tion and CPV formation have been described for this virus102. They are typically 
observed about 2 to 3 hours following alphavirus infection46. The appearance of 
the first CPVs depends on the multiplicity of infection (MOI). For example, 
CPVs can already be detected an hour after infection at a MOI of 200 whereas, 
at MOI 20, they are undetectable until 5 hours post infection134. 
1.4   Nodaviruses 
 The Nodaviridae family consists of viruses capable of replicating in a wide 
variety of invertebrates and vertebrates104. These viruses are further categorised 
as alphanodaviruses, infecting insects (examples: FHV, black beetle virus, Pari-
acoto virus) whereas betanodaviruses infect fish (examples: striped jack nervous 
necrosis virus, barfin flounder nervous necrosis virus). Betanodavirus outbreaks 
in China, Indonesia, Singapore and India affect the rearing of aquatic animals154. 
A third type of nodavirus infect shrimps and prawns (examples: Macrobrachium 
rosenbergii nodavirus and Penaeus vannamei nodavirus). These have been sug-
gested to be classified as gammanodaviruses92. 
1.4.1   Flock house virus (FHV) 
 FHV is a non-enveloped, icosahedral virus that was first isolated from 
grass grubs (Costelytra zealandica) in New Zealand120. It is a unique virus because, 
although it only infects insects, it can replicate in several species once its genome 
is introduced into cells. For instance, FHV has been seen to replicate well in the 
yeast Saccharomyces Cerevisiae104, Drosophila cells15, 105, Caenorhabditis ele-
gans73, in planta9, 157 and mammalian cells52. Recently, FHV has been suggested to 
be a prime candidate for the engineering of a virus-based RNAi delivery system 
and targeted gene silencing in insects136. 
1.4.2   FHV Viral replication and protein A 
The FHV genome, as shown in Figure 4, is capped and segmented, con-
sisting of RNA1 and RNA2. RNA1 encodes the viral replicase protein A and two 
smaller accessory proteins B1 and B2. Protein A possesses a membrane binding 
domain, self-interacts and is the RdRP26. Intact mitochondrial membranes are 
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required for FHV replication152. The RdRP domain of protein A contains a Gly-
Asp-Asp (GDD) sequence that is essential for the catalytic activity of the poly-
merase. Protein A is the only protein required for the replication of FHV141. 
RNA2 codes for the coat precursor protein alpha which is cleaved to 
generate capsid proteins and participates in the regulation of RNA3 synthesis. 
Replication of RNA1 and RNA2 occur independently of each other. In the ab-
sence of RNA2, a shutoff of RNA1 replication was seen to occur approximately 
3 days following transfection of Drosophila cells. Replication could be restored by 
transferring the intracellular RNA from the infected cells to fresh ones or by 
reactivating transcription53. Moreover, it appears that RNA3 can be replicated 
from minus-strands to plus-strands by the RdRp in the absence of RNA127. A 
region within the sequence of protein A directs the synthesis of a SgRNA, RNA3, 
from which proteins B1 and B2 are translated. RNA3 controls the production of 
RNA1 and RNA2, a vital process for regulating the expression of the viral pro-
teins and ensuring active replication28, 70, 156. The cellular decapping activators 
LSm1-7, Pat1, and Dhh1 coordinate the ratio of RNA1 to RNA3. Depletion of 
these decapping activators resulted in the accumulation of RNA3 in experiments 
performed in yeast cells by Giménez-Barcons et al40. 
B1 is encoded in the same reading frame as protein A whereas B2 is in a 
+1-reading frame compared to protein A22. The function of B1 is unknown. B2 
is involved in immune responses in insect cells and transgenic plants, acting as an 
RNAi inhibitor54, 69. The first 73 aa of B2 binds dsRNA16. This ability has been 
exploited for the design of new immunological methods as this region can be 
used as a dsRNA-specific molecular probe in vitro and in vivo84. 
While it is not required for FHV replication, B2 increases its efficiency. 
In the absence of RNA2, a boost in RNA3 synthesis is observed in yeast cells104. 
A G-to-T nucleotide substitution at position 2721 at the start of RNA3 has a 
detrimental effect on SgRNA plus-strand synthesis but minus-strand synthesis is 
not affected. This shows that this position is critical for the good functioning of 
protein A104. Protein A is a 998 aa long polypeptide and has a mitochondrial lo-
calisation signal at the N-terminus82. Protein A possesses a terminal nucleotidyl 
transferase (TNTase) capable of restoring the loss of nucleotides at the 3'-termi-
nus of the RNA template. This TNTase activity permits the reinitiating of RNA 
synthesis by a de novo mechanism153. Moreover, multiple aa sequences in protein 
A are involved in protein-protein interactions. There is likely to be a binding 
competition between these various regions of protein A suggesting that the pro-
tein has the ability to form multimers12. Moreover, tampering with these regions 
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affects FHV replication. Thus, protein A self-interactions is crucial for viral ge-
nome replication26. 
1.4.3   Spherules emerge from mitochondrial outer membrane 
Just like for alphaviruses, viral replication occurs in spherules but the 
composition is completely different as FHV spherules emerge from outer mito-
chondrial membranes83. These spherules eventually take all the mitochondrial in-
termembrane space and profoundly alter the morphology of mitochondria64, 91, 
100. The neck of the spherule provides a connection to the cytoplasm and is ap-
proximately 10 nm in diameter25. It has been hypothesised that since protein A is 
a transmembrane protein, it probably lines the interior of the spherules. Based 
on the surface area of the spherule and the size of protein A, it was previously 
assumed that about 100-150 copies of protein A could fit in a densely packed 
spherule63. Recent studies involving the analysis of these spherules using cryo-
electron tomography revealed interesting features of FHV replication. First, a 
crown-like structure was observed at the neck of the spherule, stabilising the in-
vagination as it is strongly implanted in the membrane and, monitoring the influx 
and outflow like a gate. This structure had a cup-like main body and an outer ring 
of twelve projections most likely due to the multimerisation of protein A29. Spher-
ules are very densely packed with both protein A and nucleic acids. Long fila-
ments (nascent RNA strands) were seen exiting the spherule. Investigation of the 
size of the spherules and its correlation with the length of FHV’s viral RNA pro-
poses that some spherules contain between one and three copies of dsRNA and 
synthesis of several plus-strands may occur at the same time. Moreover, it was 
suggested that each viral RNA (RNA1, RNA2 and RNA3) is replicated in its own 
Figure 4: The FHV genome is bipartite and capped. Protein A is expressed from 
RNA1, proteins B1 and B2 are expressed from RNA3. Capsid protein α is ex-
pressed from RNA2. Dotted lines represent minus-strand, SGP is the subge-
nomic promoter (modified from III). 
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spherule thus accounting for the wide range of different sizes of spherules ob-
served29. Another function of the crown could be capping of the newly synthe-
sised RNA strands as they are being pushed out of the spherules29. 
1.5   Trans-replication systems 
 Viral replication can occur either in cis (interactions within the same mol-
ecule) or in trans (interactions between different molecules). The replication of 
some positive-strand RNA viruses strictly occurs in cis. For example, the Kunjin 
virus (flavivirius) requires that some replicase proteins be translated in cis for rep-
lication to occur, thus being a limiting factor for the design of a trans-replication 
system for this virus71. Khromykh et al suggested that these cis-elements are im-
portant for the hydrophobic interactions occurring with membranes during viral 
replication61. It is possible that the presence of cis-acting elements facilitates the 
recognition of various cellular factors and viral RNAs. In the case of poliovirus, 
trans-replication can only occur in vitro but inefficiently85, 95, 130. For Tobacco mo-
saic virus, a molecular mechanism for cis-preferential replication has been pro-
posed59. For other viruses including alphaviruses, replication can occur in trans. 
Trans-replication systems have helped to elucidate  pre-requisites of replicase 
complex assembly and RNA synthesis in alphaviruses131. In a complete trans-rep-
lication system, viral protein expression is uncoupled from RNA synthesis. 
Therefore, assembly of the replicase proteins, the importance of the RNA ge-
nome and spherule formation can be studied in detail. First, it was resolved for 
SINV that the expression of an uncleavable version of P123 and nsP4 possessing 
an N-terminal tyrosine residue, making up the early replicase complex, is capable 
of minus-strand synthesis. However, further cleavage of the polyprotein into 
nsPs is required for plus-strand synthesis68. In the case of SFV, it has recently 
been established that spherules can be formed in the absence of the RNA ge-
nome. In effect, the combination uncleaved P123+nsP4 produces abundant 
spherules50. This outcome suggests that perhaps all the host factors needed for 
replication and spherule formation to occur are already present when the early 
replicase is formed. Moreover, manipulations of the RNA genome in SFV trans-
replication systems have revealed that the minus-strand formed during replica-
tion is not available for translation, re-affirming that it is well confined within the 
spherule, away from cytoplasmic events49. 
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AIMS OF THE STUDY 
 
The foremost aim of this study was to establish trans-replication systems 
specific for CHIKV and FHV. Other aims were: 
1. To individually tag CHIKV replicase proteins with fluorescent markers or 
small immunological tags. 
2. To investigate the protease activity of CHIKV nsP2. 
3. To investigate the capping activity of FHV using cell-based and in vitro assays. 
4. To compare the trans-replication systems of SFV and FHV. 
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MATERIALS & METHODS 
 
The methodology, antibodies, molecular constructs and viruses used in 
this study are listed in the tables below. An asterisk denotes the author’s contri-
bution to the method. A more detailed description can be found in the original 
publications. 
Table 2: Methods used in the study. 
Method Publication 
Cell culture  
* BHK-21 (Hamster) I, II 
* BSR T7/5 (Hamster) I, II, III 
* U2OS (Human) I 
Huh7 (Human) I 
COP-5 fibroblasts (mouse) I 
DNA/RNA transfection  
* Lipofectamine I, II 
* PEI III 
Cell manipulation  
* Isolation of crude mitochondrial pellet III 
Virological replication assays  
* Luciferase measurements (intracellular) I, III 
* In vitro replication assay (extracellular) III 
Nucleic acid techniques  
* Molecular cloning I, II, III 
* DNA and RNA isolation & purification I, II, III 
* PCR I, II, III 
* Site-directed mutagenesis I, III 
* Northern blot I, III 
* In vitro RNA transcription I, III 
Capture probe III 
Microscopy  
* Confocal microscopy I, III 
* CLEM I, III 
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Protein studies  
CD spectroscopy II 
Protease assay involving FRET (fluorescence reso-
nance energy transfer) II 
Immunological methods  
* Western blot I, III 
Data analysis  
* ImageJ I, III 
* SkanIT varioskan software III 
* Odyssey infrared imaging system III 
* Typhoon Trio imager software III 
GraphPad prism I 
 Table 3: Antibodies used in the study. 
Primary antibodies Publication 
anti-CHIKV nsP1 I, II 
anti-CHIKV nsP2 I, II 
anti-CHIKV nsP3 I, II 
anti-CHIKV nsP4 I, II 
anti-Flag I 
anti-β-actin I, II 
anti-SDHA III 
anti-dsRNA (J2) I, II, III 
anti-HA III 
anti-Tom20 III 
 
Table 4: Recombinant proteins CHIKV 
nsP2 (Publication II only). 
wt His-nsP2 
His-nsP2C478A 
His-nsP2C478A+S482A 
His-nsP2S482A 
His-nsP2W479A 
Table 5: Self-replicating replicons (pro-
ducing both replicase proteins and RNA 
template). 
CHIKV replicons Publication 
Repl-wt I 
Repl-1E I 
Repl-2E I 
Repl-3E I 
Repl-4HF I 
Repl-4SF I, II 
Repl-1E III 
 
Table 6: Viruses used in the study. 
CHIKV Viruses Publ. 
ICRES-wt I 
ICRES-4SF I 
ICRES-4HF I 
pSP6-CHIKVC478A  II 
pSP6-CHIKVW479A II 
pSP6-CHIKVS482A II 
pSP6-CHIKVC478A+S482A II 
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Table 7: SFV T7 trans-replication sys-
tems. 
SFV Replicases Publication 
P123Z4 II 
P123Z4GAA II 
P12CA3Z4 II 
P12WA3Z4 II 
P12SA3Z4 II 
P12CA+SA3Z4 II 
P123HA4 III 
P123HA4_GAA III 
SFV Templates Publication 
Tmed III 
CFP_Stluc III 
 
Table 8: FHV T7 trans-replication sys-
tems (Publication III only). 
FHV Replicases 
P_HA 
P_GAA 
P_GAA_Vis 
H93A 
R100A 
D141A 
W215A 
∆2-35A 
FHV Templates 
T_Rluc 
T_eGFP 
FHV_T 
 
 
 
 
Table 9: CHIKV trans-replication sys-
tems. 
CHIKV Replicases 
 CMV T7 Publ. 
P1234   I 
P1234-NAT   I 
P1E234-A   I 
P1E234-B   I 
P1E234-C   I 
P1E234-D   I 
P12E34-A   I 
P12E34-B   I 
P12CA34   II 
P12WA34   II 
P12CA+SA34   II 
P12SA34   II 
P123E4   I 
P123E4-GAA   I 
P1234E   I 
P1234SF   I 
P1234HF   I 
P1234HS   I 
P12EK34   I 
P12KN34   I 
P125A34   I 
P12FG34   I 
P12EKPG34   I 
P125APG34   I 
CHIKV Templates 
Fluc-Gluc   I, II 
Rluc-Tom   I, II 
Rluc-Tom-Vis   I 
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RESULTS AND DISCUSSION 
 
4.1   Ability of CHIKV to trans-replicate 
A trans-replication system uncoupling translation and replication of viral 
RNA was established for CHIKV. The cellular RNA polymerase II promoter 
was used for the generation of CHIKV RNA templates (I; Fig. 1B) while viral 
replicase protein expression was driven by the CMV promoter (I; Fig. 1A). The 
first ORF encoded Firefly luciferase (Fluc) and hence, could be expressed in the 
absence of active CHIKV replicase by the cellular machinery. The second ORF 
encoded Gaussia luciferase (Gluc) and its expression correlated with the produc-
tion of subgenomic RNAs. Thus, the expression of the second ORF in the tem-
plates of the trans-replication systems is the bona fide indicator of viral replica-
tion. We compared the Gluc activity of a CHIKV replicase plasmid, having native 
codon usage (ECSA genotype – LR2006 OPY1), to a replicase plasmid optimised 
for human codon usage, in BSR T7/5 cells, and observed a strong boost in viral 
replication from the latter (I; Fig. 1C). In order to broaden the application, five 
cell lines were chosen to be transfected with the trans-replication system, namely 
BHK-21, U2OS, Huh7, COP-5 and compared to BSR T7/5 cells. A new set of 
trans-replication system constructs (replicase plasmid and template) were de-
signed for expression in BSR T7/5 cells driven by the RNA polymerase of bac-
teriophage T7 (I; Fig. 1A). In the presence of P1234-GAA in which the poly-
merase is inactive, Fluc and Gluc were still detected at a background level. Hence, 
the fold change was calculated and analysed. Low levels of Fluc were detected 
with the CMV promoter in all cell lines but the T7-based system in BSR T7/5 
cells showed high Fluc activity. High levels of Gluc activity was seen in all cell 
lines, implicating efficient subgenomic RNA synthesis (I; Fig. 2). Next, the T7 
and CMV promoter systems were compared head-to-head based on protein ex-
pression and viral RNA synthesis in U2OS and BSR cells (I; Fig. 3). Western 
blot analysis revealed that U2OS produced the least amount nsPs compared to 
BSR T7/5 cells (T7 and CMV systems). Conversely, RNA amplification was the 
highest in U2OS cells where the levels of genomic (full length template) to sub-
genomic RNA production was rather proportionate. Viral protein production 
was the highest under the T7 promoter in BSR T7/5 cells. 
Synonymous codons have been shown to affect mRNA secondary struc-
tures, protein expression levels and protein folding96. Codon usage varies be-
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tween organisms and since CHIKV replicates in both vertebrates and mosqui-
toes, a compromise has to be reached. In the case of CHIKV trans-replication 
systems, using fully codon optimised replicase plasmids increased their perfor-
mance in a mammalian cell line. It is worth noting that the genomic RNA can be 
synthesised by the T7 RNA polymerase or cellular RNA polymerase II, thus ex-
plaining why it was also detected in the presence of the inactive replicase P1234-
GAA. A background level was always observed for Fluc activity and for Gluc to 
a lesser extent. Hence, it is important to assess the efficiency of the trans-replica-
tion system (P1234 and mutants) based on the fold change. In previous studies, 
BSR T7/5 cells have been the ‘instrument’ of choice for trans-replication systems 
but a critical limitation is that the constructs have to be T7-driven. Hence, it was 
of relevance to investigate viral replication in other cell lines and using other pro-
moter systems. We have shown that the CHIKV trans-replication system is ver-
satile and can be used in various cell lines albeit the effectiveness might not be 
always optimal. This also indicates that the efficiency of the trans-replication sys-
tem is host-specific (publication I). We observed that even when a small amount 
of replicase proteins were generated, they could be extremely active in RNA rep-
lication.  
When comparing the T7 and CMV promoters, two features should be 
taken into account: replicase proteins production and template RNA amplifica-
tion. NsPs expressed from the replicase plasmids under the T7 promoter and 
Fluc activity were at the highest level in BSR T/5 cells. BHK-21 and U2OS were 
the most efficient cell lines for the CMV-driven templates. Based on this infor-
mation, further characterisation of the CHIKV trans-replication systems was 
done using BSR T7/5 for T7-driven constructs whereas U2OS cells were used 
for the CMV-driven constructs. 
4.1.1   Successful tagging of CHIKV replicase proteins  
Four positions were chosen for the insertion of eGFP (denoted as E )at 
the C-terminus of nsP1 (P1E234-A, P1E234-B P1E234-C P1E234-D), two posi-
tions in the middle of nsP2 (P12E34-A, P12E34-B), only one position in nsP3 
(P12 3E4) and nsP4 was tagged at the C-terminus with eGFP but also combina-
tions of smaller immunological tags (P1234E, P1234SF, P1234HS, P12 34HF) (I; Fig 
4). Following transfection of each of these replicase plasmids with the Fluc-Gluc 
template, the tags were detected by Western blot thus ensuring that proper ex-
pression of the fusion proteins occurred. As predicted, a minimal effect was ob-
served on the replication activity when nsP3 was tagged. The same was seen for 
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P12E34-A. The transcription and translation activity of P12E34-B was seen to be 
reduced by 100-fold. The tags in P1E234-C and P1234SF had a milder effect on 
replication in comparison to the other constructs with modified nsP1 or nsP4. 
Viral genomes are compact and often reject insertions, such as markers 
added to the viral genome, or revert mutations in subsequent passages. This as-
pect can be problematic for the investigation of replication and virus-host inter-
actions. Trans-replication systems depict a different story as viral particles are not 
produced. CHIKV replicase proteins are known to be intolerant to modifica-
tions, especially at their N-termini. Uncoupling protein expression and RNA tem-
plate replication solves some of these problems as has previously been demon-
strated with SFV and Sindbis trans-replication systems49-50, 56, 67. However, inser-
tions in critical areas affect the stability of the protein. Previous studies involving 
SFV or CHIKV have reported that nsP2 and nsP3 can accommodate tags10 but 
nsP1 and nsP4 are known to be less tolerant20. However, in the case of P12E34-
B, the marker was inserted in the protease region of nsP2 and thus, it is possible 
that the polyprotein processing was adversely affected accounting for the fold 
reduction observed. nsP1 and nsP4 being the most problematic, it was not sur-
prising that replication was severely hampered by the insertion of eGFP. How-
ever, our results show that the C-terminus of nsP1 is suitable for the introduction 
of eGFP while nsP4 can accommodate some smaller markers such as HF without 
annihilating replication. 
4.1.2   From trans-replication systems to replicon vectors and viruses 
Based on the information obtained from the attempts to tag the replicase 
proteins in the trans-replication system, CHIKV replicon vectors were designed 
and their in vitro transcribed RNAs were transfected in BHK-21 cells. Repl-1E, 
Repl-2E, Repl-3E, Repl-4SF and Repl-4HF each harboured the tag in the position 
that exhibited the highest replication activity in the trans-replication system and 
was compared to Repl-wt (I; Fig 5A). All these constructs, except Repl-4HF, dis-
played significant cytotoxicity, suggesting competent viral RNA replication. Fur-
thermore, replicase protein expression was high and equivalent to the trans-repli-
cation system, again with the exception of Repl-4HF. The SF and HF tags in nsP4 
gave very different results in replicons which led to their investigation in the con-
text of infectious genomes (I; Fig 5C). A comparison of recombinant viruses 
ICRES-wt, ICRES-4SF and ICRES-4HF revealed that although their level of pro-
tein expression was similar, the infectivity of the tagged versions was lower, with 
ICRES-4HF being the lowest. Additionally, further analysis revealed that ICRES-
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4HF had eventually lost the tag probably due to genetic instability. In replicon 
experiments, Repl-4HF showed poor expression of nsP2 and nsP4 accounting for 
the instability caused by tagging the C-terminus of nsP4 with the HF combination 
tag. 
4.1.3   Subcellular localisation of replicase proteins using CHIKV repli-
cons and a trans-replication system in U2OS cells 
Using tagged CHIKV replicon vectors and trans-replication constructs, it 
is possible to localise the replicase proteins in cells. The template T7-Rluc-Tom 
was used in which the Tomato marker is expressed from the second ORF under 
the control of CHIKV subgenomic promoter (I; Fig 1B – last two constructs). 
Hence, only cells displaying red fluorescence were analysed. Replicons and trans-
replication systems presented the same features: nsP1 was found primarily on the 
plasma membrane, nsP2 mostly in the nucleus, nsP3 was seen strongly clustered 
in the cytoplasm while nsP4 was scattered throughout the cytoplasm.   
Notably, all the cells exhibiting red fluorescence harboured active viral 
replication and, for the trans-replication system, the transfection efficiency was 
about 20% (unpublished data). The aforementioned cellular locations of the nsPs 
correspond to the excess replicase proteins that are not part of the replication 
complex and are probably interacting with host factors. Furthermore, the trans-
replication system is, to some extent, an ‘artificial’ system and nsPs are continu-
ously being generated. Similar subcellular localisations of nsPs outside of the rep-
lication complex had previously been observed for untagged infectious CHIKV 
viruses118. Detection of replicase complexes is impossible at this resolution. 
Moreover, it is probable that each replication complex contains a low amount of 
nsPs, which may not be enough for detection by fluorescence microscopy. The 
important indicator of viral replication, the intermediate dsRNA, was detected 
primarily on the plasma membrane for all tagged replicon and trans-replication 
constructs. Since all nsPs come from a polyprotein, one would expect that they 
exist in the cell in equal numbers but a discrepancy was observed in the intensity 
of eGFP and anti-Flag conjugated antibodies. For example, nsP3 was always eas-
ily identified, perhaps due to the aggregation. However, nsP4 often displayed 
much weaker signals probably because of its targeted degradation. 
4.1.4   Spherule formation in CHIKV using trans-replication systems 
Abundant spherules were detected in tagged and untagged CHIKV trans-
replication systems (I; Fig 7). They were single-membraned, adjoined to the 
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plasma membrane, pouch-like and with a neck structure opening towards the 
cytoplasm. An electron-dense dot-like structure can be seen in the middle and is 
believed to be condensed nucleic acid. The spherules detected with the CHIKV 
trans-replication system were similar to those observed in previous studies with 
SFV50, 131. These invaginations are the site of active viral RNA synthesis and are 
very rarely seen in the presence of the inactive polymerase expressed from P1234-
GAA (T7 and CMV). Furthermore, spherule formation was not affected by the 
presence of the tags in CHIKV replicases. 
4.1.5   Requirements for CHIKV nsP2 protease activity 
The protease region of nsP2 was fused to a histidine tag (His) at the N-
terminus and purified as an active recombinant protein. Mutated versions were 
also made including C478A (Cysteine 478 residue of CHIKV nsP2 to Alanine), 
S482A (Serine 482 residue to Alanine), the combination (C478A + S482A) and 
W479A (Tryptophan 479 residue to Alanine). These mutant proteins were able 
to fold similarly to His-nsP2 (wildtype), with no detectable structural deformity, 
except for the W479A mutant that showed abnormally high ellipticity (II; Fig 2b 
& c). C478A and W479A hampered the ability of nsP2 to cleave 1/2 and 3/4 
sites (II; Fig 5). The mutations were transferred to SFV and CHIKV trans-repli-
cation systems, under the T7 promoter, for transfection in BSR T/5 cells. Tmed 
and T7_Rluc_Tom were used for with the SFV and CHIKV replicase plasmids 
respectively. Northern blot experiments revealed that genomic and subgenomic 
viral RNA synthesis was abolished for the mutants with the exception of the 
S482A mutant (II; Fig 6). S482A produced slightly more minus-strands than the 
control P1234. To confirm the ability of S482A to replicate, BHK-21 cells were 
infected with CHIKV harbouring the S482A mutation at MOI 10 (II; Fig 8). 
Numerous spherules were observed at the plasma membrane as well as internal-
ised CPVs containing spherules.   
Previous studies have shown that the nsP2 of alphaviruses acts similarly 
to papain-like proteases41. We observed that the substrate requirements of 
CHIKV nsP2 protease were similar to those of SFV nsP2. Contrary to a previous 
study115, the Ser482 residue in the active site of CHIKV nsP2 does not compen-
sate for the loss of the Cys478 residue. For different alphaviruses the correspond-
ing position can be occupied also by Cys or Thr residues indicating that some 
variation is tolerated at position 482. The protease region of nsP2 in alphaviruses 
is very conserved. Hence, it can be hypothesised that an antiviral inhibiting the 
protease activity of one alphavirus will most likely inhibit the others as well. The 
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role of the Cys478 residue in the catalytic site of nsP2 protease was found to be 
critical for polyprotein processing and viral replication. Moreover, the C478A 
mutant blocked all the essential biological activities of the corresponding repli-
cases and viruses. The strange folding capabilities observed with W479A recom-
binant protein might be the result of enzymatically inactive aggregates.  
4.1.6   RNA replication and cytotoxicity 
Replicase constructs harbouring mutations thought to impact the cyto-
toxic effect of nsP2 were designed for analysis in a trans-replication system with 
the template CMV-Fluc-Gluc, in U2OS cells (I; Fig 8A). These mutations were 
Pro718 to Gly (PG), Lys192 to Asn (KN), Glu117 to Lys (EK), the insertion of 
five amino acids after residue 647 of nsP2 (5A), as well as combinations such as 
EKPG and 5APG. Western blot analysis (I; Fig 8B & 8C) revealed that KN, 
PG and EKPG enhanced the production of nsPs whereas EK had no effect on 
replicase protein expression. The 5A and PG mutations on their own resulted in 
a slight increase in nsP2 compared to P1234 but did not affect replication. How-
ever, the combination 5A+PG did not have an effect on nsP2 expression and 
Gluc activity was hindered. A significant reduction in Gluc activity was also ob-
served from the EK, EKPG while the KN mutation was lethal for viral replica-
tion (I; Fig 8C). 
nsP2 is known for causing a strong cytopathic effect and, causes tran-
scriptional and translational shutdown in cells35. Previous studies with SFV have 
demonstrated that 5APG and EKPG reduce cytotoxicity135. It had also been 
shown that viruses harbouring EK and EKPG were too unstable to allow any 
kind of investigation of functionality140 but with the trans-replication system, it 
was possible to observe the decrease in subgenomic RNA production with EK 
and EKPG. It is interesting that even though the KN mutation provided a boost 
in nsP expression, the change was not reflected in viral replication. This indicates 
that high protein expression levels do not automatically result in more efficient 
viral replication. This observation could be further confirmed by examining the 
effects of EK and EKPG. EK clearly hampered viral replication and although 
PG boosted protein expression, it did not compensate for the loss of viral repli-
cation activity. It is possible that KN affects NTPase, helicase and/or RNA tri-
phosphatase activities which are vital for CHIKV replicase function. While 5A 
and PG mutations on their own did not affect subgenomic RNA synthesis, to-
gether they had a negative effect on viral replication. Therefore, I hypothesise 
that 5APG gives rise to a version of nsP2 in which folding is affected, possibly 
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hindering the protease catalytic domain (there is evidence that 5APG reduces the 
rate of polyprotein processing140), or renders nsP2 less efficient in participating 
in viral replication complex formation thus impeding the viral RNA synthesis. 
4.2   FHV trans-replication system; uncoupling viral protein expression 
and RNA Synthesis 
As mentioned in the introduction, FHV is one of the simplest viruses 
known as only protein A and the RNA template are required for viral replication. 
The design of an FHV specific trans-replication system was established under the 
control of the T7 promoter for use in BSR T7/5 cells. The replicase plasmid 
P_HA corresponds to FHV RNA1 with the addition of an HA tag at the C-
terminus of protein A, less the 5' and 3' UTRs (III, Fig 1b). P_GAA contains a 
double missense mutation in the catalytic domain of the polymerase. The tem-
plate plasmid T_Rluc contains the UTRs, includes a frameshift that prevents the 
expression of protein A and Rluc marker inserted under the control of the sub-
genomic promoter, in fusion with the B2 open reading frame. Following trans-
fection in BSR T7/5 cells, protein A was expressed from P_HA and recruited 
the RNA template generated from the T_Rluc construct. This resulted in high 
levels of Rluc detected in BSR T7/5 cells and extremely high viral RNA synthesis, 
thus demonstrating the efficiency of FHV trans-replication system (III, Fig 1d & 
1e). The GAA mutation did not hinder protein expression and did not yield any 
RNA transcript. 
BSR T7/5 cells had been formerly used for SFV and CHIKV trans-repli-
cation systems (I, II) and had proven to yield high levels of RNA transcripts. It 
was earlier mentioned that, in the case of CHIKV T7-driven P1234-GAA, ge-
nomic RNA was detected in BSR T7/5 cells at very low levels. Similar, to these 
previous studies, mRNAs of template plasmids can be transcribed intracellularly 
by the T7 polymerase thus accounting for the background levels of Rluc detected 
with P_GAA + T_Rluc and T_Rluc transfected alone. Interestingly, these afore-
said combinations did not produce genomic or subgenomic viral RNA at detect-
able levels. Therefore, it seems that the T7 RNA polymerase produces less 
mRNA transcripts (background) in the FHV trans-replication system than in the 
CHIKV trans-replication system but these transcripts are replicated very effi-
ciently in the presence of the active FHV polymerase. 
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4.2.1   Mitochondria act as replication niches for FHV replication 
Subcellular localisation of protein A was studied using the template 
T_eGFP that expresses green fluorescence upon activation of the subgenomic 
promoter (III; Fig 2a). Using antibodies to detect the HA tag and Tom-20 (mi-
tochondrial import receptor subunit TOM20 homolog), protein A was found to 
be strictly associated with mitochondria as expected. Moreover, the presence of 
dsRNA was indicative that mitochondria was the location of active viral RNA 
synthesis. P_GAA was also localised in mitochondria, due to the mitochondrial 
membrane anchor domain within protein A. However, no dsRNA was detected 
for P_GAA. 
Spherules generated by the FHV trans-replication system arose from 
outer-mitochondrial membranes in cells harbouring active viral replication (III; 
Fig 2b). All the mitochondria in each replicating cell exhibited this phenotype. 
The morphology of mitochondria was severely altered; the intermembrane space 
appeared swollen to make space for the spherule and the cristae were barely vis-
ible. Considering the late timepoint chosen after transfection, it is not surprising 
that no intermediate structures were seen. A previous study by Kopek et al de-
scribed a ‘zippering’ effect of mitochondria following transfection in Drosophila 
cells with protein A alone. In their experiment, the outer membranes of mito-
chondria tightly connected and clustered with projections interlocking like a zip-
per64. This effect was not observed in our experiments. Finally, there were no 
spherules when P_HA alone was transfected. 
4.2.2   Temperature is a key factor for FHV replication in cells and in vitro 
Several methods were attempted for the isolation of mitochondria fol-
lowing transfection of P_HA + T_Rluc in BSR T7/5 cells (unpublished data).  
Ultimately, a differential centrifugation protocol based on Frezza et al 32 produced 
a crude mitochondrial pellet (CMP) of suitable purity and was chosen for sample 
preparation. The CMP was used in an in vitro replication assay (IVRA) previously 
described to be efficient for FHV replication123. High synthesis of both genomic 
and SgRNA was observed after an incubation of 90 minutes at 30°C (III; Fig 
3a). Further characterisation of the FHV IVRA showed that the first transcripts 
were detected within the first 30 minutes of the reaction (III; Fig 3b). To inves-
tigate the effect of temperature on RNA synthesis, the IVRA was performed at 
25°C, 30°C and 37°C (III; Fig 3c). Expectedly, fewer RNA transcripts were de-
tected at 25°C. However, a substantial increase in RNA synthesis was observed 
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at 37°C. Nevertheless, the other IVRA experiments were performed at 30°C un-
less stated otherwise. The ability of protein A to remain active at 37°C in vitro 
challenges results obtained in BSR T7/5 cells as shown in Figure 5 and Figure 6. 
When P_HA + T_Rluc was transfected into BSR T7/5 cells followed by incuba-
tion at 37°C, the luciferase signal obtained did not go much beyond background 
levels (Figure 5) although protein A was expressed (Figure 6). 
Since FHV’s primary hosts are insects, the preferred temperature for ex-
periments in BSR T7/5 cells was 28°C. The fact that protein A was inactive when 
expressed in cells at 37°C suggested that an important replication step is temper-
ature sensitive. Therefore, the increase in RNA synthesis at 37°C in vitro was very 
surprising. It could be that the assembly of the FHV’s replication complex is a 
sensitive process requiring the temperature to be 28°C but, once formed, can 
perform at higher temperatures. Alternatively, mitochondria might be operating 
at different temperatures than the rest of the cell and enzymes taking part in the 
respiratory chain function maximally at about 50°C17. Chrétien et al stated that 
Figure 5: FHV trans-replication at 37°C. 
BSR T7/5 cells were transfected with the 
indicated plasmids and luciferase activity 
was measured after 40 hours. The cells 
were kept at 37°C at all times. No signif-
icant difference was seen between P_HA 
+ T_Rluc and the background levels. 
Figure 6: Protein A expression at 37°C. 
BSR T7/5 cells were transfected with 
P_HA and incubated for 18 hours at 
37°C. Protein A was detected using α-
HA antibodies, seen in green. Nuclei are 
shown in cyan. 
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the temperature of mitochondria (at least in HEK293 cells) is regulated by the 
rate of respiratory electron flux. Considering the substantial morphological 
changes mitochondria undergo during FHV replication, it can be assumed that 
the respiratory chain is affected. Moreover, the CMP isolation procedure might 
exacerbate those changes thus, explaining why this disparity in the temperature 
phenotype was observed. 
4.2.3   FHV replicates only the endogenous RNA template and synthesises 
plus-strands in vitro 
We attempted to resolve whether an already-formed FHV replication 
complex can recruit an exogenous RNA template. A new template, FHV_T was 
designed by deleting the Renilla luciferase marker from T_Rluc, thus making it 
shorter. The new combination P_HA+FHV_T was transfected in BSR T7/5 
cells, the CMP was isolated and RNA synthesis was observed under IVRA con-
ditions (III; Fig 3e). When an in vitro transcribed T_Rluc RNA (capped or un-
capped) was added prior to the IVRA, genomic and SgRNA was observed again 
with sizes corresponding to FHV_T but not T_Rluc. This showed that the CMP 
was unable to replicate an externally provided RNA template. A CMP prepara-
tion containing only protein A showed no activity in the IVRA.  
The polarity of the RNA products generated in the IVRA was determined 
based on their binding affinity to radioactively labelled capture probes specific to 
either the plus-strand or the minus-strand. RNA synthesised in vitro from 
P_HA+T_Rluc CMP strongly hybridised with the plus-strand probe and insig-
nificantly (similar to the background) hybridised to the minus-strand probe.  
An IVRA specific for FHV was previously described by Short et al123. In 
their experiments, they claimed that: 1) CMP isolated from infected Drosophila 
cells was poorly reactivated in vitro, and 2) providing an exogenous RNA template 
to the IVRA boosted replication. Contrary to these claims, we observed a robust 
reactivation of viral replication with the endogenous RNA in vitro. These differ-
ences could be the result of hosts specific mechanisms: Drosophila cells are fun-
damentally different from BSR T7/5 cells. Moreover, Short et al used wildtype 
viruses as opposed to the trans-replication system in our case. The question of 
whether an already formed viral replication complex can recruit another RNA 
template has been attempted for SFV but not resolved57, 101. Even though we 
clearly demonstrated that the CMP cannot replicate an exogenous template, it 
does not exclude the possibility that this RNA could still be recruited by the rep-
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lication complex. The IVRA generated predominantly RNA transcripts of posi-
tive sense. Formation of spherules is believed to occur upon minus-strand syn-
thesis. Since the mitochondria in the CMP are most likely already saturated with 
spherules, presumably no new spherules were formed in the IVRA. Moreover, 
protein A present in the spherules in the CMP was already interacting with a 
minus-strand and therefore there was no need for the generation of new minus-
strands. Another explanation, although doubtful, could be that the CMP lacked 
some unknown host factors necessary for the production of the minus-strand. 
Ertel et al suggested that the crown structure made at the neck of FHV spherules 
is formed first and RNA is then recruited to the membrane29. While we have not 
investigated spherule formation following CMP isolation and IVRA, it is proba-
bly not the case. In the IVRA, adding in vitro transcribed T_Rluc to a CMP prep-
aration transfected with only P_HA did not yield any RNA transcripts. There-
fore, this suggests that the introduction of the RNA template at a later time point 
affects viral replication. 
4.2.4   FHV capping domain and replicase protein mutants 
Four of the most conserved aa residues in the putative capping domain 
of protein A (N-terminus) were mutated in an attempt to investigate the role of 
the capping activity in viral replication. The residues H93, R100, D141 and W215 
were mutated to Ala. The P_GAA (inactivated polymerase mutant) and ∆2-35 
(membrane-binding domain deletion) were taken as controls. The replicase mu-
tants were transfected in BSR T7/5 cells together with T_Rluc. Even though the 
mutations did not affect protein expression (III; Fig 4b), viral replication was 
abolished for all the mutants except for the W215A mutant. W215A showed 
some activity but the luciferase signal was markedly reduced compared to P_HA 
(III; Fig 4a). Active viral RNA synthesis both in cells and in vitro (III; Fig 4c & 
d) was not detected for all replicase mutants with the exception of W215A which 
showed faint bands corresponding to the genomic and SgRNA. In an attempt to 
rescue viral replication, the replicase mutants were transfected in BSR T7/5 cells 
together with an in vitro transcribed T_Rluc RNA. Again, W215A was the only 
replicase mutant capable of replication (III; Fig 5). 
W215 corresponds to an important, highly conserved tyrosine residue in 
alphaviruses3-4. It appears that W215 plays a lesser role in replication compared 
to the other residues. This is in contrast to what was observed in earlier studies 
involving SFV and Brome mosaic virus (BMV), where mutating the correspond-
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ing tyrosine residue abolished replication1, 57. Thus, there might be some mecha-
nistic differences in RNA synthesis and RNA capping between these two virus 
groups.  H93 has been suggested as the covalent guanylate site involved in RNA 
capping4, R100 is a highly conserved charged residue3 and D141 residue is 
thought to bind S-adenosylmethionine4. Interestingly, mutating these three resi-
dues prevented RNA synthesis completely and the effect cannot be rescued by 
providing an already capped RNA. It could be that these residues in the putative 
capping domain of FHV are also involved in the recruitment of the viral RNA 
during replication complex formation. 
4.2.5   A comparison of SFV and FHV trans-replication systems 
The features of the SFV trans-replication system have been described in 
previous studies51, 56, 131. Here, we used P123HA4 which produces nsPs 1-4 and 
nsP3 is fused with an HA tag. The template T_med consisted of Rluc under the 
T7 promoter and a Tomato fluorescent marker under the subgenomic promoter. 
CFP_Stluc consisted of a cyan fluorescent protein under the control of the T7 
promoter and Rluc under the subgenomic promoter. P123HA4-GAA was used 
as a control since it contains a mutation in the catalytic domain of the SFV poly-
merase in nsP4 (III; Fig 6a). Both the SFV (P123HA4+Tmed and 
P123HA4+CFP_Stluc) and the FHV (P_HA+T_Rluc) trans-replication systems 
were transfected in BSR T7/5 cells. The SFV system was incubated at 37°C 
whereas the FHV system was incubated at 28°C. Luciferase signals measured af-
ter 16 hours and 40 hours respectively were very high, well above the background 
levels obtained with the GAA mutant (III; Fig 6b). When the same combina-
tions were tested in Northern blot using a probe that recognises the Rluc se-
quence (III; Fig 6c), active RNA synthesis was observed in all combinations that 
included an active replicase. Based on their replication and viral RNA synthesis 
levels and compared to their inactivated polymerase counterpart, the FHV trans-
replication system appears to be more efficient than the SFV trans-replication 
system. 
To test whether SFV and FHV can replicate in the same cell, BSR T7/5 
cells were transfected with the SFV combination P123HA4+Tmed and the FHV 
P_HA+T_eGFP altogether. The cells were kept at 28°C (not an optimal temper-
ature for SFV) and analysed by immunofluorescence after 40 hours. Three phe-
notypes were observed; green from eGFP (FHV replication only), red from the 
tomato marker (SFV replication only) and in some cells both signals were seen 
38 
 
(III; Fig 6d). CLEM experiments were performed to verify whether the two vi-
ruses could form their spherules in the same cell.  Only the cells expressing both 
red and green immunofluorescence signals were analysed. Unfortunately, only 
SFV spherules were seen at the plasma membrane whereas the mitochondria 
looked normal. The SFV (red) immunofluorescence signal was strong showing 
that the trans-replication system worked quite well even under suboptimal condi-
tions. This experiment had a few obstacles. First, the transfection efficiency was 
very low. In fact, the transfection efficiency of the T7-driven CHIKV trans-repli-
cation system was found to be about 18 % when only two plasmids (unpublished 
data) were transfected. Hence this ratio is expected to be much lower when trans-
fecting four plasmids. Secondly, it is possible that even though all plasmids are 
introduced in the same cell, the replicase proteins are not able to find and recruit 
their corresponding template. Although we did not quantify the immunofluores-
cence signals, we observed that, in cells where both signals were seen, the green 
to red ratio was disproportionate. For example, the green signal detected from 
cells replicating both systems was much weaker than in cells were only FHV was 
replicating. Likewise, for SFV, cells replicating only SFV trans-replication system 
displayed a much stronger red phenotype compared to those where both FHV 
and SFV were replicating. Both systems are competing for the same T7 polymer-
ase so it would be interesting to test whether this observation would arise if they 
would use different promoter systems. Both systems could also be competing for 
the same host factors. If this were the case, it would indicate that SFV and FHV 
use similar replication strategies even though the membrane requirement is dif-
ferent. It was unexpected that the CLEM experiment did not show FHV spher-
ules as the green signal arises from SgRNA synthesis, which is the hallmark of 
viral replication. A possible explanation would be that usually only one system 
could establish a high-level replication in an individual cell. 
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Interestingly, transfection of the replicase plasmid in DNA form and the 
template as an in vitro transcribed capped RNA resulted in active replication al-
most as robust as when both are transfected as DNA (III; Fig 5). Hence a similar 
experiment was done with SFV trans-replication system in BSR T7/5 cells as 
shown in Figure 7. Here again, transfection of the DNA+RNA combination 
worked unexpectedly well. The replicase plasmid, being in DNA form upon 
transfection, would have to undergo transcription and translation. Thus, we 
thought that the RNA template would have been already degraded by the time 
the replicase proteins are translated and available for recruitment. The fact that 
this unusual combination worked so well further testifies to the adaptability of 
trans-replication systems. 
 
  
Figure 7: Alphavirus trans-replication 
with combined DNA and RNA transfec-
tion. BSR T7/5 cells were transfected 
with the combinations shown. P123Z4 
was transfected as DNA and Tshort as 
DNA or RNA. Luciferase activity was 
measured after 16 hours. 
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CONCLUDING REMARKS 
 
The main focus of the study was to investigate the interactions between 
the viral replicases and the RNA genome as well as spherule formation for 
CHIKV and FHV by means of trans-replication systems. Additionally, SFV and 
FHV trans-replication systems were compared. 
The main findings and further questions include: 
I. The CHIKV trans-replication system mimics viral replication and can be 
adapted for use in various cell lines. However, the efficiency is host-spe-
cific. The CHIKV trans-replication system allowed the visualisation of 
nsP1 on the plasma membrane, nsP2 in the nucleus, nsP3 in cytoplasmic 
aggregates, nsP4 scattered in the cytoplasm and spherules at the plasma 
membrane. Next, it would be interesting to investigate the functions of 
the C-terminus of nsP1 and nsP4 by mutagenesis using the trans-replica-
tion system. 
II. Cys478 and Trp479 residues are crucial for the protease activity of 
CHIKV nsP2 while the substitution of Ser482 to Ala has a negligible ef-
fect. In the future, it would be interesting to know what’s happening in 
the interplay of P125A34 and P12PG34, is nsp2 being degraded instead of 
rpb1? Is the flexibility of the protease domain reduced? Is the catalytic 
rate more active? 
III. The FHV trans-replication system revealed abundant spherules associated 
with the outer membrane of mitochondria. FHV protein A is inactive in 
BSR T7/5 cells but active in vitro at 37°C. Only the endogenous template 
was replicated in vitro and the RNA transcripts generated were of positive 
polarity.  Mutating the conserved residues H93, R100 and D141 abol-
ished viral replication which could not be rescued by providing an already 
capped RNA genome. The elucidation of the specific mechanisms of the 
FHV capping domain and its influence on viral replication will open new 
avenues in terms of antivirals because of its similarities with alphaviruses 
and capping enzymes are promising antiviral targets. 
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